Abstract
Introduction
Pancreatic acinar cell carcinoma (ACC) is a rare tumor with poorly defined prognosis.
Objective
Our objective was to compare a large population of patients with ACC to pancreatic ductal cell adenocarcinoma (DCC) in order to determine distinguishing characteristics and to assess survival.
Methods
Patients were identified from the National Cancer Database. Regression methods were used to identify differences between ACC and DCC and to identify predictors of survival for resected ACC. Eight hundred sixty-five patients with ACC were identified.
Results
Median tumor size was 6.9 cm (vs. 4.6 cm DCC); 32.1% had nodal metastases (vs. 48.0% DCC); and 47% had high-grade tumors (vs. 37.3% DCC). Resection margins were R0 77.3%, R1 13.7%, and R2 9.0%. Patients with ACC were more likely to be male, white, and have larger tumor size, no nodal involvement, or pancreatic tail tumors. Stage-specific 5-year survival was significantly better for resected ACC vs. DCC Stage I: 52.4% vs. 28.4%, II: 40.2% vs. 9.8%, III: 22.8% vs. 6.8%, and IV: 17.2% vs. 2.8%. On multivariable analysis, age < 65, well-differentiated tumors, and negative resection margins were independent prognostic factors for ACC.
Discussion
ACC carries a better prognosis than DCC. Aggressive surgical resection with negative margins is associated with long-term survival in these more favorable pancreatic cancers.
Similar content being viewed by others
References
Webb JN. Acinar cell neoplasms of the exocrine pancreas. J Clin Pathol 1977;30:103–112. doi:10.1136/jcp.30.2.103.
Klimstra DS, Heffness CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas: A clinicopathologic study of 28 cases. Am J Surg Pathol 1992;16:815–837. doi:10.1097/00000478-199209000-00001.
Ordonez NG, Mackay B. Acinar cell carcinoma of the pancreas. Ultrastruct Pathol 2000;24(4):227–241. doi:10.1080/01913120050176680.
Sumii T, Funakoshi A, Ouchi J. Suizou 2001;16:455–459. Japanese.
Holen KD, Klimstra DS, Hummer A, Gonen M, Conlon K, Brennan M, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol 2002;20:4673–4678. doi:10.1200/JCO.2002.02.005.
Chiou YY, Chiang JH, Hwang JI, Yen CH, Tsay SH, Chang CY. Acinar cell carcinoma of the pancreas: clinical and computed tomography manifestations. J Comput Assist Tomogr 2004;28(2):180–186. doi:10.1097/00004728-200403000-00005.
Seth AK, Argani P, Campbell KA, Cameron JL, Pawlik TM, Schulick RD, et al. Acinar cell carcinoma of the pancreas: An institutional series of resected patients and review of the current literature. J Gastrointest Surg 2008;12(6):1061–1067. doi:10.1007/s11605-007-0338-1.
Matos JM, Schmidt CM, Niedergethmann M, Saeger HD, Merchant N, Lillemoe KD, et al. Pancreatic acinar cell carcinoma: a multi-institutional study. Beverly: SSAT, 2008.
Kitagami H, Kondo S, Hirano S, Kawakami H, Egawa S, Tanaka M. Acinar cell carcinoma of the pancreas: Clinical analysis of 115 patients from pancreatic cancer registry of Japan Pancreas Society. Pancreas 2007;35(1):42–46. doi:10.1097/mpa.0b013e31804bfbd3.
Winchester DP, Stewart AK, Bura C, Jones RS. The national cancer data base: A clinical surveillance and quality improvement tool. J Surg Oncol 2004;85(1):1–3. doi:10.1002/jso.10320.
Bilimoria K, Stewart AK, Winchester DP, Ko CY. The national cancer data base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2007;15(3):683–690.
World Health Organization. International Classification of Disease for Oncology, 3rd ed. Geneva: World Health Organization, 2000.
Commission on Cancer. Standards of the Commission on Cancer Volume II. Registry Operations and Data Standards. Chicago: Commission on Cancer, 1998.
Commission on Cancer. Facility Oncology Registry Data Standards. Chicago: Commission on Cancer, 2004.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 2007;110(4):738–744. doi:10.1002/cncr.22852.
AJCC. Cancer Staging Manual AJCC, 6th ed. Chicago: Springer, 2002.
Hosmer J, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1999.
Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481. doi:10.2307/2281868.
Cox D. Regression models and life tables. J R Stat Soc [Ser A] 1972;34(2):187–220.
Berner P. Subkutane fettgewebsnekose. Virchow Arch Path Anat 1908;193:510–518. doi:10.1007/BF01989526.
Klimstra DS, et al. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 1992;16(9):815–837. doi:10.1097/00000478-199209000-00001.
Seth AK, et al. Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature. J Gastrointest Surg 2008;12(6):1061–1067. doi:10.1007/s11605-007-0338-1.
Kitagami H, et al. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society. Pancreas 2007;35(1):42–46. doi:10.1097/mpa.0b013e31804bfbd3.
Robertson JC, Eeles GH. Syndrome associated with pancreatic acinar cell carcinoma. BMJ 1970;2(5711):708–709.
Acknowledgements
KYB is supported by the American College of Surgeons, Clinical Scholars in Residence program.
Author information
Authors and Affiliations
Corresponding author
Additional information
Grant Support: KYB is supported by the American College of Surgeons, Clinical Scholars in Residence program.
Rights and permissions
About this article
Cite this article
Schmidt, C.M., Matos, J.M., Bentrem, D.J. et al. Acinar Cell Carcinoma of the Pancreas in the United States: Prognostic Factors and Comparison to Ductal Adenocarcinoma. J Gastrointest Surg 12, 2078–2086 (2008). https://doi.org/10.1007/s11605-008-0705-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-008-0705-6